Skip to main content

Home/ Dr. Goodyear/ Group items tagged profession

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
1More

http://care.diabetesjournals.org/content/33/11/2390.full.pdf - 0 views

care.diabetesjournals.org/...2390.full.pdf metabolic syndrome metabolic syndrome profession
shared by Nathan Goodyear on 26 Sep 14 - No Cached
  • Nathan Goodyear on 26 Sep 14
     
    Now this is an interesting study--metabolic syndrome rates of US professions.
1More

Reduced intravenous glutathione in the treatment of early parkinson's disease 10.1016/S... - 0 views

www.sciencedirect.com/...S0278584696001030 IV intravenous glutathione Parkinson's disease PD
shared by Nathan Goodyear on 09 Mar 12 - No Cached
  • Nathan Goodyear on 09 Mar 12
     
    IV glutathione shown to slow profession of Parkinson's Disease.  IV was given at doses of 600 mg IV twice daily for 30 days.
1More

Analysis of Relations between serum levels of Epitestosterone, Estradiol, Testosterone,... - 0 views

www.biomed.cas.cz/...49_S113.pdf PSA hormone hormones BPH Prostate cancer prostate cancer Epitestosterone men male aromatase Estradiol IGF-1
shared by Nathan Goodyear on 21 Aug 13 - No Cached
  • Nathan Goodyear on 21 Aug 13
     
    Great confusion exists in the medical profession about Testosterone and PSA and the health of the prostate. The conversion of Estrogen, whether E2 or E1, and other variables are responsible for increases in PSA while on Testosterone therapy. This study points out that Estradiol in men stimulates cell line growth of prostate cancer. In contrast, Epitestosterone, an androgen metabolite, has antiandrogen, inhibits this estrogen activity. Epitestosterone exists in an inverse relationship to Estradiol and IGF-1.
1More

Prostate Cancer and Prostatic Diseases - Androgen dynamics and serum PSA in patients tr... - 0 views

www.nature.com/...pcan20148a.html ADT androgen deprivation therapy male hormone hormones prostate cancer PSA disease
shared by Nathan Goodyear on 31 Mar 14 - No Cached
  • Nathan Goodyear on 31 Mar 14
     
    ADT therapy with abiraterone inhibits androgen production from both testicular and adrenal origins.  This study finds that a decrease in androgen production through ADT did not always equal a decrease in PSA, indicating other mechanisms of prostate cancer profession.
1 - 4 of 4
Showing 20▼ items per page